GOSSAMER BIO, INC. (GOSS) /

The profitability of GOSSAMER BIO, INC. over the past 9 years

Chart GOSSAMER BIO, INC.: operating income, net income, fiscal 2017–2025 Open the chart →

GOSSAMER BIO, INC. reported a net loss of $170.37M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $170.73M. It reported a loss in all 9 years shown.

Year by year

Fiscal yearOperating incomeNet income
2025ended Dec 31, 2025-$170.73M-$170.37M
2024ended Dec 31, 2024-$59.92M-$56.53M
2023ended Dec 31, 2023-$183.76M-$179.82M
2022ended Dec 31, 2022-$218.59M-$229.38M
2021ended Dec 31, 2021-$216.12M-$234M
2020ended Dec 31, 2020-$233.96M-$243.36M
2019ended Dec 31, 2019-$186.14M-$180.31M
2018ended Dec 31, 2018-$148.99M-$146.97M
2017ended Dec 31, 2017-$6.65M-$6.77M

Fiscal years as GOSSAMER BIO, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on GOSSAMER BIO, INC.

Companies of a similar size

Not investment advice. This page shows what GOSSAMER BIO, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.